Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ pAd/BLOCK-iT™-DEST RNAi Gateway Vector

Catalog No. V49220
Encompass_Preferred
Click to view available options
Quantity:
6 μg

Requires

Additional materials required, available separately: Gateway entry clone, Gateway LR Clonase™ enzyme mix, and reaction buffer.

State-of-the-art Gateway destination vectors

Invitrogen offers state-of-the-art Gateway destination vectors for expression in E. coli, insect, yeast, or mammalian cells, as well as for production of native protein or N- or C-terminal fusion proteins. All Gateway destination vectors have attR sites for recombination with any attL-flanked fragment, regardless of whether it is an entry clone or an Ultimate™ RF Clone. A wide range of destination vectors is available.

  • All destination vectors are provided lyophilized and supercoiled

Adenoviral shRNA, Cloning, Gateway Cloning, RNAi, RNAi, Epigenetics and Non-Coding RNA Research, Virus-Based RNAi

Order Info

Shipping Condition: Dry Ice

TRUSTED_SUSTAINABILITY

Specifications

Constitutive or Inducible System Constitutive
Delivery Type Adenoviral
Promoter U6
Product Type RNAi Gateway Vector
Content And Storage All destination vectors are provided lyophilized and supercoiled.
Cloning Method Gateway
Quantity 6 μg
Vector pAd, pDEST
Product Line BLOCK-iT™, Gateway™

For Research Use Only. Not for use in diagnostic procedures.

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.